RT Journal Article
SR Electronic
T1 An Aberration Detection-Based Approach for Sentinel Syndromic Surveillance of COVID-19 and Other Novel Influenza-Like Illnesses
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.08.20124990
DO 10.1101/2020.06.08.20124990
A1 Andrew Wen
A1 Liwei Wang
A1 Huan He
A1 Sijia Liu
A1 Sunyang Fu
A1 Sunghwan Sohn
A1 Jacob A. Kugel
A1 Vinod C. Kaggal
A1 Ming Huang
A1 Yanshan Wang
A1 Feichen Shen
A1 Jungwei Fan
A1 Hongfang Liu
YR 2020
UL http://medrxiv.org/content/early/2020/06/09/2020.06.08.20124990.abstract
AB Coronavirus Disease 2019 (COVID-19) has emerged as a significant global concern, triggering harsh public health restrictions in a successful bid to curb its exponential growth. As discussion shifts towards relaxation of these restrictions, there is significant concern of second-wave resurgence. The key to managing these outbreaks is early detection and intervention, and yet there is significant lag time associated with usage of laboratory confirmed cases for surveillance purposes. To address this, syndromic surveillance can be considered to provide a timelier alternative for first-line screening. Existing syndromic surveillance solutions are however typically focused around a known disease and have limited capability to distinguish between outbreaks of individual diseases sharing similar syndromes. This poses a challenge for surveillance of COVID-19 as its active periods are tend to overlap temporally with other influenza-like illnesses. In this study we explore performing sentinel syndromic surveillance for COVID-19 and other influenza-like illnesses using a deep learning-based approach. Our methods are based on aberration detection utilizing autoencoders that leverages symptom prevalence distributions to distinguish outbreaks of two ongoing diseases that share similar syndromes, even if they occur concurrently. We first demonstrate that this approach works for detection of outbreaks of influenza, which has known temporal boundaries. We then demonstrate that the autoencoder can be trained to not alert on known and well-managed influenza-like illnesses such as the common cold and influenza. Finally, we applied our approach to 2019-2020 data in the context of a COVID-19 syndromic surveillance task to demonstrate how implementation of such a system could have provided early warning of an outbreak of a novel influenza-like illness that did not match the symptom prevalence profile of influenza and other known influenza-like illnesses.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported in this publication was supported by the National Center for Advancing Translational Science of the National Institutes of Health under award number U01TR002062. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research was reviewed and approved by the Mayo Clinic Institutional Review Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to the results of the symptom extraction process being considered protected health information, data is not available as it would be difficult to distribute to anyone not engaged in an IRB-approved collaboration with the Mayo Clinic. The NLP engine and associated algorithm used to extract ILI symptoms as described in this study is available within the MedTagger project (https://www.github.com/OHNLP/MedTagger). Please consult the Wiki and README file accessible from the linked page for instructions on how to use for the COVID-19 use case. The aberration detection/sentinel syndromic surveillance component has been decoupled from institutional data sources and is available at https://github.com/OHNLP/AEGIS. As this is an active project undergoing improvement and new features that may lead to changes in the underlying code inconsistent with what was described in this manuscript, we have tagged the codebase as described in this manuscript with the COVID19 tag. https://github.com/OHNLP/AEGIS https://github.com/OHNLP/MedTagger